Tilus, Mercilyn G.
HRN: 03-96-19 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/11/2024
CO-AMOXICLAV 625MG (TAB)
01/11/2024
01/17/2024
PO
625mgtqb
Q8
Cap Lr
Checking Final Appropriateness